---

Cardiology Cath Lab Equipment: Contrast Agents, Guiding Catheters, Guidewires & Sheaths

---

1. CONTRAST AGENTS IN CARDIOLOGY

What They Do

Types of Contrast Media

Pharmacology and Properties

• Iodine concentration: Determines radiodensity. Typical coronary injections use agents with 320-370 mgI/mL.
• Viscosity: Higher viscosity slows injection through smaller catheters - critically important with 5-6 Fr guiding catheters, where flow rate is limited.
• Iodine delivery rate: A function of catheter lumen diameter, catheter length, contrast viscosity, and injection pressure. Using a 5 Fr guide in an obese patient is the "ultimate challenge" for coronary opacification quality.
• Temperature: Warming contrast to 37°C reduces viscosity significantly, improving flow through narrow catheters.

Contrast and Clotting

• All contrast agents have anticoagulant effects to varying degrees.
• Non-ionic agents have weaker anticoagulant effects than ionic agents in vitro, but this does NOT translate to a "thrombogenic potential" clinically.
• There is no proven correlation between major adverse cardiac events after PCI and the type of contrast agent used.
• Non-ionic agents significantly reduce the rate of adverse drug reactions (ADRs) during both diagnostic catheterization and PCI.

Adverse Reactions

• Ionic agents (e.g., ioxaglate): Early reactions in ~22% of patients undergoing cardiac catheterization.
• Non-ionic monomers (e.g., iopamidol): Early reactions ~8.8%; late skin reactions ~4.2%.
• Iodixanol (iso-osmolar): Early reactions ~7.6%, but higher late skin reactions (~12.2%) - an important nuance.
• Reactions range from mild flushing/nausea to anaphylaxis and contrast-induced nephropathy (CIN).

Contrast-Induced Nephropathy (CIN)

• Risk rises with pre-existing CKD, diabetes, high contrast volumes, and dehydration.
• NGAL (neutrophil gelatinase-associated lipocalin) in urine/plasma detects CIN earlier than serum creatinine.
• Mitigation: hydration, minimize contrast volume, use iso-osmolar contrast (iodixanol) in high-risk patients, consider CO₂ angiography for non-coronary vessels in severe CKD.

CO₂ as a Contrast Agent

• First used intra-arterially in the 1970s; became practical only after DSA (digital subtraction angiography) in 1980.
• Used primarily for peripheral and renal angiography - not for coronary arteries (risk of gas embolism).
• Ideal for patients with severe iodine allergy or advanced renal failure.

---

2. INTRODUCER SHEATHS

Purpose

Anatomy of a Sheath

1. Access needle (18-21 gauge, 2-5 cm long)
2. Guidewire (short, 30-50 cm, J-tip or straight)
3. Dilator (inner tapered tube to create the tract)
4. Sheath itself (outer tube with hemostasis valve + sidearm for flushing/drug delivery)

Sizing

• Measured in French (Fr) - each Fr = 0.33 mm outer diameter
• Diagnostic angiography: 4-6 Fr (most common)
• PCI/intervention: 6-7 Fr standard; 8 Fr for complex cases
• TAVR, LVAD, large-bore procedures: up to 14-24 Fr
• Sheaths > 10 Fr are reserved for structural interventions

Sheath Length

• Standard (11 cm): Most diagnostic and coronary procedures
• Long sheaths (23-45 cm): Tortuous iliac vessels, severe peripheral disease, radial artery spasm prevention
• In radial access for PCI, longer sheaths reduce spasm and provide smoother guide catheter movement

Access Routes

Sheathless Systems

• Systems like Eaucath (Asahi) and Railway (Cordis) allow 6.5-7.5 Fr equivalent catheters without a traditional sheath.
• 1-2 Fr smaller footprint on the artery - reduces radial artery stretch.
• Trade-off: less consistent backup and catheter manipulation vs. traditional sheathed systems.

---

3. GUIDING CATHETERS

What They Do

1. A stable platform (backup support) for advancing balloons, stents, wires, and devices
2. A conduit for contrast injection to visualize the vessel
3. A conduit for pressure waveform monitoring

Construction (3 Layers)

1. Inner layer: Lubricious PTFE (polytetrafluoroethylene) - reduces friction on wires and devices
2. Middle layer: Stainless steel braiding - provides hoop strength and support
3. Outer layer: Soft nylon elastomer jacket - atraumatic contact with vessel walls

Guiding Catheter Sizes

Guide Catheter Shapes (Most Common)

Backup Support

Pressure Damping Warning

Guide Catheter Extensions

• e.g., GuideLiner, GuidExtend, GUIDEZILLA II - telescoping micro-catheters inserted through the guide to extend deep into the coronary artery.
• Used for extremely tortuous anatomy, calcified vessels, or when extra "deep seating" support is needed.

---

4. CORONARY GUIDEWIRES

Purpose

Wire Anatomy

• Tip: Soft, shapeable, radiopaque - crosses lesions atraumatically
• Core: Central shaft providing torque transmission and pushability
• Coating: PTFE or hydrophilic polymer for lubricity
• Diameter: Standard coronary wires are 0.014" (0.36 mm)

Key Wire Properties

Wire Classification by Use Case

• e.g., BMW, Runthrough NS, Fielder, CHOICE Floppy
• Tip load: 0.5-2 g; soft polymer tip
• Used for: straightforward lesions, routine PCI

• e.g., LUGE, Prowater
• More backbone for delivering stiff devices through curves

• e.g., Iron Man, Rotafloppy (for rotational atherectomy)
• Used when devices won't advance without rail support

• e.g., PT2 LS, Fielder XT
• Hydrophilic polymer jacket on tip - highly slippery
• Navigate tight, tortuous, or calcified segments
• Higher risk of subintimal passage if over-manipulated

• e.g., Conquest Pro, Pilot series, Gaia series
• High tip load (5-20 g); tapered tip; designed to penetrate fibrous/calcified caps
• Retrograde techniques use wires passed from the contralateral coronary artery via collaterals

• e.g., PressureWire X (Abbott), Comet (Boston Scientific)
• Contain a pressure sensor near the tip
• Used to measure Fractional Flow Reserve (FFR): ratio of distal hyperemic pressure to aortic pressure
• FFR > 0.80 = lesion non-significant; FFR ≤ 0.80 = intervention indicated
• Also used for iFR (instantaneous wave-free ratio) - no adenosine needed

• Standard 0.014" wires - IVUS catheter advanced over the wire into the coronary artery
• Provide cross-sectional imaging: plaque burden, calcium, stent apposition

Wire Lengths

• 190 cm: Standard length for most PCI procedures
• 300 cm: Used for over-the-wire (OTW) balloon exchanges where wire must stay in position

---

5. HOW THEY ALL WORK TOGETHER - THE PCI SEQUENCE

1. Radial/femoral puncture with access needle (21-gauge micropuncture system)
2. Short guidewire (0.035", J-tip, 30-50 cm) introduced through the needle
3. Introducer sheath (typically 6 Fr for PCI) placed over the wire with dilator, providing stable arterial access with hemostasis valve
4. Guiding catheter (e.g., JL 3.5 for LCA) advanced over a 0.035" wire through the sheath to the coronary ostium; wire removed
5. Contrast injection through the guide catheter for diagnostic angiography - identifies lesion
6. Coronary guidewire (0.014", e.g., BMW or workhorse wire) shaped at tip and advanced through the guide into the coronary artery, crossing the lesion
7. Balloon/stent advanced over the 0.014" guidewire, positioned at lesion
8. Further contrast injections through the guide confirm position
9. Post-dilation, OCT/IVUS wire as needed
10. Sheath removal and vascular closure (manual pressure, closure device, TR band for radial)

---

6. QUICK REFERENCE: CONTRAST + EQUIPMENT INTERACTIONS

---

---

Contrast Media and Its Side Effects - Complete Reference

---

OVERVIEW OF CONTRAST MEDIA TYPES

---

ACR CLASSIFICATION OF ADVERSE REACTIONS

---

CATEGORY 1: ALLERGIC-LIKE REACTIONS (ALR)

Mechanism

1. Release of vasoactive substances - primarily histamine
2. Activation of complement, kinin, coagulation, and fibrinolytic cascades
3. Inhibition of cholinesterase - causes prolonged vagal stimulation
4. Patient anxiety and fear (psychogenic augmentation)

Timing

• Immediate: within 1 hour of injection (usually within 20-30 minutes)
• Delayed: 1 hour to 7 days after injection

Severity Classification

MILD ALR

• Scattered urticaria / skin flushing
• Pruritus (itching)
• Nasal congestion / rhinorrhoea
• Mild nausea, warmth sensation
• Brief sneezing

MODERATE ALR

• Diffuse urticaria
• Facial or laryngeal oedema
• Mild bronchospasm / wheeze / dyspnoea
• Prolonged nausea/vomiting
• Tachycardia or bradycardia (haemodynamically stable)

SEVERE ALR - Life-Threatening

• Severe bronchospasm / overt laryngeal oedema (stridor)
• Hypotensive shock
• Pulmonary oedema
• Respiratory or cardiac arrest
• Convulsions / loss of consciousness
• Angioedema

Incidence

---

CATEGORY 2: PHYSIOLOGIC (NON-ALLERGIC) REACTIONS (PR)

Subcategories

• Transient warmth/flushing
• Nausea, vomiting
• Metallic taste in mouth

• Bradycardia + hypotension (vasovagal)
• Can mimic severe allergy but responds to atropine and leg elevation

• Negative inotropy (reduced cardiac contractility) - relevant in poor LV function
• Transient ECG changes
• Arrhythmias with intra-arterial injection

• Headache, dizziness
• Rare: seizures, cortical blindness (usually transient) with intrathecal or high-dose intra-arterial use

• Exacerbation of pre-existing asthma (patients with asthma have 10x higher risk of severe reaction)

---

DELAYED REACTIONS (1 hour to 7 days)

• Skin: itching, rash/urticaria, hives - most common
• Gastrointestinal: nausea, vomiting, diarrhoea
• General: headache, dizziness, fever, myalgia

• ~12.2% with iodixanol
• ~4.3% with ioxaglate
• ~4.2% with iopamidol

---

RISK FACTORS FOR ADVERSE REACTIONS

Important: Shellfish allergy and iodine-containing topical preparations (e.g., povidone-iodine) do NOT cross-react with iodinated contrast media and are NOT a contraindication. This is a common misconception. - ACC 2025

---

TREATMENT OF ADVERSE REACTIONS

Mild ALR

• Maintain IV access; observe
• Usually self-limiting; no treatment needed
• Consider oral antihistamine if pruritus bothersome

Moderate ALR

• Diphenhydramine (Benadryl) IV/IM
• IV H2 blocker
• Supplemental oxygen

Severe Reactions - by Symptom

---

PREMEDICATION (for patients with prior reactions)

• Prednisone 50 mg oral at 13 hours, 7 hours, and 1 hour before contrast
• Plus diphenhydramine 50 mg IV/IM/oral 1 hour before contrast
• Consider switching to a different contrast agent class (different non-ionic agent or gadolinium for MRI if appropriate)

---

CONTRAST-INDUCED NEPHROPATHY (CIN) / POST-CONTRAST AKI (PC-AKI)

Definitions (ACR / AKIN / KDIGO)

• Diagnosed if ANY of the following occur within 48 hours of contrast injection:
  • Serum creatinine rises ≥ 0.3 mg/dL (≥ 26.4 µmol/L), OR
  • Creatinine rises ≥ 50% (1.5x above baseline), OR
  • Urine output ≤ 0.5 mL/kg/h for ≥ 6 hours

Clinical Course

• Creatinine rises within 24 hours, peaks at 96 hours, returns to baseline within 7-10 days in most patients
• Can be asymptomatic
• Patients who develop PC-AKI have longer hospital stays, higher mortality, and higher rates of cardiac and neurological events (though some of this may be due to underlying disease rather than contrast itself)

Risk Thresholds (eGFR-based)

For IV contrast CT, the risk of CIN may be lower than historically believed. Studies by McDonald et al. found IV contrast was not independently associated with increased nephrotoxicity even in CKD. However, intra-arterial contrast (angiography) carries a higher risk as the renal bolus is more concentrated and abrupt, compared to IV injection.

Risk Factors for CIN

• Pre-existing CKD (most important)
• Diabetes mellitus
• Dehydration / volume depletion
• Heart failure / low cardiac output
• Large contrast volumes
• Nephrotoxic drugs (NSAIDs, aminoglycosides, ACE inhibitors given simultaneously)
• Multiple contrast exposures in short intervals

Prevention of CIN

---

METFORMIN AND CONTRAST - CURRENT GUIDELINES (ACR 2024)

---

THYROID EFFECTS OF IODINATED CONTRAST

• Most individuals escape this effect after 1-2 weeks - no permanent harm
• Susceptible populations who may NOT escape:
  • Pre-existing Graves' disease
  • Multinodular goitre
  • Elderly patients (>65 years)
  • Patients with cardiovascular disease
  • Iodine-deficient patients
  • Neonates and infants (especially with congenital heart disease or very low birth weight)

• Iodine-induced hyperthyroidism (Jod-Basedow phenomenon): in patients with pre-existing autonomous thyroid nodules
• Transient hypothyroidism: particularly in neonates after cardiac imaging

• Avoid radioactive iodine thyroid treatment for 4-8 weeks after iodinated contrast
• For high-risk patients (elderly + severe cardiovascular disease), consider measuring thyroid function before administration
• Do NOT routinely check thyroid function before contrast in all patients

---

GADOLINIUM-BASED CONTRAST AGENTS (GBCA) - SPECIFIC RISKS

Nephrogenic Systemic Fibrosis (NSF)

• Rare, serious, potentially fatal complication - skin thickening, limb contractures, disability
• Occurs almost exclusively in patients with severe renal failure (eGFR < 15-30)
• Caused by gadolinium deposition in tissues in renally impaired patients
• Macrocyclic agents (gadoterate, gadobutrol, gadoteridol) are most stable and have the lowest NSF risk - preferred in all patients with eGFR < 30
• For eGFR < 15 or dialysis patients: avoid GBCAs if at all possible; if needed, use only macrocyclic agents; space repeat injections ≥ 7 days

Gadolinium Deposition

• Trace amounts of gadolinium deposit in brain (dentate nucleus, globus pallidus), bone, and other tissues after repeated GBCA use
• Seen on MRI as T1 signal in dentate nucleus
• No proven clinical harm established, but the finding is acknowledged in guidelines

---

SPECIAL SITUATIONS IN CARDIOLOGY

---

• Campbell-Walsh-Wein Urology (9780323546423) - Adverse Reactions to Intravascular Contrast Media
• Brenner and Rector's The Kidney (9780323532655) - PC-AKI and CIN
• ACR Manual on Contrast Media 2024
• PMC - Adverse Reactions to Iodinated Contrast Media
• ACC 2025 - Contrast Media in Advanced Cardiovascular Imaging
• PMC - Best Practices for Vascular Arterial Access

---

Side Holes in Catheters - Complete Reference

---

WHAT ARE SIDE HOLES?

1. End hole only - diagnostic selective catheters (Judkins, Amplatz, etc.)
2. End hole + side holes - flush catheters (pigtail, NIH, Lehman)
3. Side holes only, no end hole - Berman angiographic catheter

---

WHY SIDE HOLES ARE USED - CORE FUNCTIONS

1. High-Volume, High-Rate Contrast Injection

• Can traumatize the endocardium or vessel wall
• Can dislodge thrombus or atherosclerotic plaque
• Causes the catheter to recoil forcefully backward (Newton's third law - jet recoil effect)

2. Preventing Pressure Damping / Catheter Wedging

• Pressure damping (pressure waveform loses diastolic component)
• Ventriculization of the pressure waveform
• Ischaemia and risk of VF if injection proceeds

However - side holes restore the pressure signal but do NOT fully restore coronary blood flow. Also, contrast injected through side holes may require higher volumes and produce suboptimal opacification.

3. Reducing Catheter Recoil

• Dislodge the catheter from its position
• Cause unintended movement within the ventricle/aorta
• Trigger ectopic beats from mechanical stimulation

4. Drainage / Sampling Over a Wide Area

5. Reducing Ventricular Ectopy

---

CARDIAC CATHETERS WITH SIDE HOLES - DETAILED TABLE

A) DIAGNOSTIC / FLUSH CATHETERS

• Prevents the end hole from directly contacting the endocardium (reducing perforation risk and ectopy)
• The loop uncurls when a guidewire is inserted, allowing the catheter to be advanced safely through vessels

B) BERMAN ANGIOGRAPHIC CATHETER (Side Holes Only - No End Hole)

• Because there is no end hole, wedge pressure cannot be measured with the standard Berman
• The balloon provides stability during angiography (no recoil from side hole jets)
• Available in 4-8 Fr, lengths 50-110 cm

C) GUIDING CATHETERS - SIDE HOLES

Key Clinical Point: Side holes on a guiding catheter can be a double-edged sword - they restore the pressure waveform and reduce ischaemia during wedging, but they can falsely reassure the operator that there is no problem, masking a dangerous ostial obstruction. Careful pressure waveform interpretation is mandatory.

D) SWAN-GANZ / PULMONARY ARTERY CATHETER - MULTI-PORT DESIGN

---

NON-CARDIAC CATHETERS WITH SIDE HOLES

---

COMPLICATIONS RELATED TO SIDE HOLES

1. Jet Effect / Subintimal Injection

• Subintimal extravasation of contrast
• Vessel wall dissection or injury
• Most common in flush catheters during high-pressure aortography

2. Masked Pressure Damping (Guiding Catheters)

3. Fibrin Sheath Formation (CVCs/PD Catheters)

• Ability to flush but inability to aspirate ("can flush, can't draw back")
• Complete catheter malfunction
• Fix: thrombolytics (urokinase/tPA), fibrin sheath stripping, or catheter exchange

4. Occlusion by Adjacent Structures (PD Catheters)

• Omental wrap (most common)
• Stool-filled bowel loops
• Visceral adhesions Result: one-way flow - can fill but not drain, or vice versa

5. Reduced Contrast Efficiency (Guiding Catheters)

---

SUMMARY: WHEN TO CHOOSE SIDE-HOLE CATHETERS

---